AcelRX Pharmaceuticals Stock Quote ACRX - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
AcelRX Pharmaceuticals Inc (ACRX) Quote

AcelRX Pharmaceuticals Inc (ACRX)

0.86

0.00

(0.00%)

Closed June 26 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

0.86

Bid

0.861

Ask

0.89

Volume

-

0.00 Day's Range 0.00

0.425 52 Week Range 1.38

Market Cap

Previous Close

0.86

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

16,952,000

Dividend Yield

-

PE Ratio

-0.82

Earnings Per Share (EPS)

-1.09

Revenue

651k

Net Profit

-18.4M

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

talphera.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

AcelRX Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACRX. The last closing price for AcelRX Pharmaceuticals was $0.86. Over the last year, AcelRX Pharmaceuticals shares have traded in a share price range of $ 0.425 to $ 1.38.

AcelRX Pharmaceuticals currently has 16,952,000 shares outstanding. The market capitalization of AcelRX Pharmaceuticals is $15.09 million. AcelRX Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.82.

FeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0.08	10.2564102564	0.78	0.8775	0.7211	203144	0.76849051	CS
52	-0.29	-25.2173913043	1.15	1.38	0.425	207536	0.79277872	CS
156	-28.34	-97.0547945205	29.2	31	0.425	912066	9.73190468	CS
260	-43.14	-98.0454545455	44	60.4	0.425	1331629	26.22994658	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WENAANEW MEDICAL INC	$ 3.61 (118.79%)	89.77M
CMAXCareMax Inc	$ 3.40 (78.95%)	13.76M
FFIEFaraday Future Intelligent Electric Inc	$ 0.4562 (72.15%)	665.83M
OPTXSyntec Optics Holdings Inc	$ 3.85 (63.83%)	35.43M
MEDSTRxADE HEALTH Inc	$ 11.85 (35.12%)	383.69k
BJDXBluejay Diagnostics Inc	$ 1.6293 (-40.75%)	2.49M
GRIGRI Bio Inc	$ 1.8493 (-37.73%)	774.11k
LYELLyell Immunopharma Inc	$ 1.30 (-36.27%)	11.88M
NUWENewellis Inc	$ 0.1404 (-35.54%)	11.3M
CNSPCNS Pharmaceuticals Inc	$ 1.88 (-33.80%)	1.54M
FFIEFaraday Future Intelligent Electric Inc	$ 0.4562 (72.15%)	665.83M
NVDANVIDIA Corporation	$ 126.40 (0.25%)	362.26M
RIVNRivian Automotive Inc	$ 14.74 (23.24%)	261.97M
SQQQProShares UltraPro Short QQQ	$ 8.18 (-2.50%)	109.65M
TSLATesla Inc	$ 196.37 (4.81%)	95.72M

skitahoe

skitahoe 4 minutes ago

Thanks, it sounds like they just might be paying some lawyers to work on Sunday to put the final touches on everything. If that turns out to be the case, next Monday could be exciting.

I would suspect that if this fails to happen, it will take a lot of work, but they can put it back

skitahoe

skitahoe 4 minutes ago

Thanks, it sounds like they just might be paying some lawyers to work on Sunday to put the final touches on everything. If that turns out to be the case, next Monday could be exciting.

I would suspect that if this fails to happen, it will take a lot of work, but they can put it back

The Night Stalker

The Night Stalker 5 minutes ago

Waverunners

Waverunners 6 minutes ago

I’m here to have debates and offer fact based opinions. I can successfully go back and forth with anyone, as I have absolute confidence in my research.
However, I can see that he is struggling mightily and likely needs a break from discussion boards, as he feels any conflicting views must

Jrossco

Jrossco 6 minutes ago

8 days is at or around 7/3. Is that the best day to put out news given the 4th is a holiday?

georgejjl

georgejjl 6 minutes ago

Trofinetide for the treatment of Rett syndrome:

The most common adverse events in LILAC were diarrhea (74.7%), vomiting (28.6%), and COVID-19 (11.0%). Diarrhea was the most common adverse event leading to treatment withdrawal (21.4%).

Compared to Anavex's blarcames

Destiny Defined

Destiny Defined 7 minutes ago

Imagine how your parents must feel. 🥺

okwife

okwife 7 minutes ago

$BTC DOWN when $USD UP!! https://stockcharts.com/freecharts/gallery.html?$USD

JRoon71

JRoon71 7 minutes ago

That's certainly positive thinking. 🤣

But I believe if Hikma thinks there is risk of multi-hundred million dollar damages (or more), they will figure out a way to settle long before that ever comes to be.

I could see them agreeing to settle by exiting the IPE m

Stef07

Stef07 8 minutes ago

You’re wrong again it was a Blog dedicated to patents. And those statistics are pretty simple. Won or Lost/ Denied or Instituted/ this isn’t like one of your posts were you never give VP the benefit of your doubts. Your posts are all inaccurate, you claim you know it all, but that is were you are w

StormyVolcano1

StormyVolcano1 8 minutes ago

Ron YOU ARE THE ONLY ONE who I trust.
What is your opinion on the amount per escrow common share and the timing?

ProLiberty

ProLiberty 9 minutes ago

Aren't chances of a settlement high? Given that the valuation of the company is effectively zero net of cash at the moment, a fast $100-200m settlement (as well as Hikma dropping their case) could be worth it?

It is also possible a buyer in the wings might be interested in buying Amar

janice shell

janice shell 9 minutes ago

I'm just the messenger. That's all they've said about it.

cowtown jay

cowtown jay 9 minutes ago

It's really not that hard to figure out. The key is the amended Asset Purchase Agreement (APA).

That unleashing of additional Milestone Events, and increased payments from reaching those Milestone Events, would satisfy all financial obligations to all classes of creditors, and lead t

Monroe1

Monroe1 9 minutes ago

bingo, you just won the big door prize. excellent basher analysis.

Rkf302

Rkf302 9 minutes ago

Might be your greatest post

NoMoDo

NoMoDo 10 minutes ago

Still 27 days to cover. I am expecting a decent covering from the last 2 weeks. Maybe 350k shares covered? WAG only. That would put us at about 11-12% of float (float is 10.9mil). At increased daily volume, that could bring the days to cover to around 18 days. That would relieve some of the sh

The Night Stalker

The Night Stalker 10 minutes ago

excel

excel 10 minutes ago

I can see this happening unfortunately .............

https://scontent-sea1-1.xx.fbcdn.net/v/t39.30808-6/449241547_8408728369157132_4123476120671191819_n.jpg?_nc_cat=110&ccb=1-7&_nc_sid=833d8c&_nc_ohc=zksTBCjx_3EQ7kNvgHwut62&_nc_ht=scontent-sea1-1.xx&oh=00_AYB_sroCoCusCea0gNTckSfaeqiHs

zandant

zandant 10 minutes ago

French Fried....just like this sad "company."

kayak_wench

kayak_wench 11 minutes ago

So all the folks slapping down on people saying they thought the company could be diluting need to back off the next time someone posts that. Its not at all an obscene amount. It is staying pretty constant and not unexpected. As I posted earlier, it is looking like the company is diluting a chunk

MPstock

MPstock 11 minutes ago

I'm still thinking we hit 95.00 by the end of the year. Gonna stick with this prediction regardless of the possibility of being wrong.

Monroe1

Monroe1 11 minutes ago

Don't be too panicky now. The AI scanner may give you a depression alert.

WALL STREET KID

WALL STREET KID 11 minutes ago

🔥🩳🔥 Buckle up #APES because today's update is packed with thrilling insights into why $AMC is massively undervalued and poised for a monumental short squeeze.

With institutional manipulation, order imbalances, and the resilience of retail investors, the stage

AcelRX Pharmaceuticals

Delayed Upgrade Clock